Couples in whom the man is HIV-1-positive may use medically assisted procreation in order to conceive a child without contaminating the female partner. But, before medically assisted procreation, the semen has to be processed to exclude HIV and tested for HIV nucleic acid before and after processing
Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE network
✍ Scribed by Christophe Pasquier; Corinne Andreutti; Evelyne Bertrand; Alionka Bostan; Thomas Bourlet; Irene Molina; Zehava Grossman; Philippe Halfon; Marianne Leruez-Ville; Margrethe Lüneborg-Nielsen; Carmen Mar; Anne-Geneviève Marcelin; Catherine Roussel-Ronserail; Marie-Paule Schmitt; Sepehr Tabrizi; Maria Vourliotis; Louis Bujan
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 79 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Detection of HIV‐1 RNA in semen is used commonly to determine the safety of semen processing procedures before assisted reproductive technology (ART). Using two panels of prepared semen samples containing HIV‐1 the performances of protocols from 14 centers have been compared. No false‐positive results were detected but false‐negative results were frequent when the concentration was below 500 HIV‐1 RNA copies/ml of seminal plasma. Frequency of HIV‐1 RNA detection was higher on seminal cells than on seminal plasma. Assays (or protocols) for quantifying HIV‐1 RNA in semen performed less well than standardized blood plasma assays. The HIV load in seminal plasma could be a useful marker of the risk of sexual transmission of the virus. Its use as a marker of global HAART efficiency in the HIV reservoir needs further study. Standardized assays are required for detection and measurement of HIV‐1 RNA in semen samples. J. Med. Virol. 84:183–187, 2012. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
Peripheral blood mononuclear cells from HIV-1 -infected persons were mixed with 5 M guanidine thiocyanate, and HIV-1 -specific probes were hybridized with target RNA directly in the lysate. No RNA purification was needed. Hybrids were purified by repeated capture on superparamagnetic beads coated
A quantitative human immunodeficiency virus type 1 (HIV-1) RNA polymerase chain reaction assay has been validated analytically and clinically in > 13,000 samples. The assay is highly reproducible with intra-and inter-assay precision of 16% and 19%, respectively. In 1,542 of 1,548 subjects with CD4'
## Abstract Diagnosis of primary HIV‐1 infection is challenging due to the presence of a serological window; thus, HIV‐1‐RNA quantitation and/or measurement of p24 antigenemia are recommended in such cases. A patient was diagnosed at the time of primary HIV‐1 infection, he harbored a CFR02\_AG subt
The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV-1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV-1 subtype C infect
## Abstract ## Purpose To derive reproducibility assessments of ejection fraction (EF) and left ventricular mass (LVM) from short‐axis cardiac MR images acquired at single and multiple time‐points on different 1.5T scanner models. ## Materials and Methods Images of 15 healthy volunteers were acq